Dr. Carson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
675 N Saint Clair St
Ste 21-100
Chicago, IL 60611Phone+1 312-695-6180Fax+1 312-695-1106
Education & Training
- McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2005 - 2008
- Duke University HospitalResidency, Internal Medicine, 2000 - 2003
- Keck School of Medicine of the University of Southern CaliforniaClass of 2000
Certifications & Licensure
- FL State Medical License 2024 - Present
- IL State Medical License 2004 - 2026
- MO State Medical License 2008 - 2024
- NC State Medical License 2003 - 2005
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Clinical Trials
- T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma Start of enrollment: 2006 Sep 01
- Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma Start of enrollment: 2011 Oct 01
- Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma Start of enrollment: 2012 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Association between glucagon-like peptide-1 receptor agonist use and progression of monoclonal gammopathy of uncertain significance to multiple myeloma among patients ...Nikhil Grandhi, Lawrence Liu, Mei Wang, Theodore Thomas, Martin Schoen
JNCI Cancer Spectrum. 2024-11-01 - A SONAR report on Nirmatrelvir/ritonavir-associated rebound COVID-19: Using new databases for evaluating new diseases.Charles L Bennett, Joseph Magagnoli, Krishna Gundabolu, Peter Georgantopoulos, Akida Lebby
Plos One. 2024-01-01 - 17 citationsSurvival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases.Martin W Schoen, Kenneth R Carson, Seth A Eisen, Charles L Bennett, Suhong Luo
Prostate Cancer and Prostatic Diseases. 2023-12-01
Journal Articles
- Prevalence of High Tumor Mutational Burden and Association with Survival in Patients with Less Common Solid TumorsKenneth Carson, MD, JAMA Network Open
Abstracts/Posters
- Approximating International Myeloma Working Group Uniform Response Criteria to Derive Response for Multiple Myeloma (MM) Patients Using Data from Electronic Health Rec...Kenneth R. Carson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Romidepsin in Combination with Gemcitabine, Oxaliplatin, and Dexamethasone Shows Durable Responses in Aggressive LymphomasKenneth R. Carson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Real-World Application of National Comprehensive Cancer Network (NCCN) Testing Guidelines in Diffuse Large B-Cell Lymphoma (DLBCL) Results in Underdiagnosis of Double-...Kenneth R. Carson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Hepatitis B Testing Rates in Patients with Chronic Lymphocytic Leukemia before and during Administration of Anti-CD20 Therapy2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Predicting Risk of Venous Thromboembolism in Multiple Myeloma: The Impede VTE Score2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Committees
- Member, 2015 Update Committee, American Society of Clinical Oncology (ASCO) 2015 - Present
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: